Decreased regulatory T-cells and CD4(+) /CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo

Pigment Cell Melanoma Res. 2013 Jul;26(4):586-91. doi: 10.1111/pcmr.12105. Epub 2013 May 13.

Abstract

The aim of present study was to evaluate CD4(+) /CD8(+) ratio and CD4(+) CD25(hi) FoxP3(+) Tregs in GV patients with reference to their effect on disease onset and progression. Flow cytometry was used for determination of CD4(+) /CD8(+) ratio and Tregs in 82 patients and 50 controls. CD8(+) T-cell counts were significantly higher in GV patients as compared with controls (p = 0.003). Active GV patients showed higher CD8(+) T-cell counts compared with stable GV patients (p = 0.001). The CD4(+) /CD8(+) ratio decreased significantly in patients as compared with controls (p = 0.001). Moreover, the ratio in active GV patients significantly lowered as compared with stable GV patients (p = 0.002). Significant decrease in Treg cell percentage and counts in GV patients was observed compared with controls (p = 0.009, p = 0.008) with significant reduction in FoxP3 expression (p = 0.024). Treg cell percentage and counts were significantly decreased in active GV patients compared with stable GV patients (p = 0.007, p = 0.002). Our results suggest that an imbalance of CD4(+) /CD8(+) ratio and natural Tregs in frequency and function might be involved in the T-cell mediated pathogenesis of GV and its progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Autoimmunity
  • CD4-CD8 Ratio*
  • Disease Progression
  • Female
  • Flow Cytometry
  • Forkhead Transcription Factors / metabolism
  • Humans
  • Immunotherapy
  • Interleukin-2 Receptor alpha Subunit / metabolism
  • Male
  • Melanocytes / cytology
  • Middle Aged
  • Pigmentation
  • T-Lymphocytes, Regulatory / cytology*
  • Vitiligo / blood*
  • Vitiligo / physiopathology*
  • Young Adult

Substances

  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Interleukin-2 Receptor alpha Subunit